Symbol
ERAS on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Ownership
12.3M shares
Security Ownership
4.4%

Novartis Pharma AG ownership in Erasca, Inc. Common Stock (ERAS)

2025-02-12 - Novartis Pharma AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.3M shares of Erasca, Inc. Common Stock (ERAS). This represents 4.4% percent ownership of the company.